HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms

被引:35
|
作者
Andrew, Amy [1 ]
Strebel, Klaus [1 ]
机构
[1] NIAID, Viral Biochem Sect, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
关键词
Vpu; Degradation of CD4; HIV-1; release; BST-2; beta-TrCP; VIRUS TYPE-1 VPU; PROTEIN-U VPU; SIMIAN-IMMUNODEFICIENCY-VIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; FULL-LENGTH VPU; CYTOPLASMIC DOMAIN; PARTICLE RELEASE; ENVELOPE GLYCOPROTEIN; TRANSMEMBRANE DOMAIN; ENDOPLASMIC-RETICULUM;
D O I
10.1016/j.mam.2010.08.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vpu is a small integral membrane protein encoded by HIV-1 and some SIV isolates. The protein is known to induce degradation of the viral receptor molecule CD4 and to enhance the release of newly formed virions from the cell surface. Vpu accomplishes these two functions through two distinct mechanisms. In the case of CD4, Vpu acts as a molecular adaptor to connect CD4 to an E3 ubiquitin ligase complex resulting in CD4 degradation by cellular proteasomes. This requires signals located in Vpu's cytoplasmic domain. Enhancement of virus release on the other hand involves the neutralization of a cellular host factor, BST-2 (also known as CD317, HM1.24, or tetherin) and requires Vpu's TM domain. The current review discusses recent advances on the role of Vpu in controlling degradation of CD4 and in regulating virus release. Published by Elsevier Ltd.
引用
收藏
页码:407 / 417
页数:11
相关论文
共 50 条
  • [1] HIV-1 Vpu Antagonizes BST-2 by Interfering Mainly with the Trafficking of Newly Synthesized BST-2 to the Cell Surface
    Dube, Mathieu
    Paquay, Catherine
    Roy, Bibhuti Bhusan
    Bego, Mariana G.
    Mercier, Johanne
    Cohen, Eric A.
    TRAFFIC, 2011, 12 (12) : 1714 - 1729
  • [2] βTrCP is Required for HIV-1 Vpu Modulation of CD4, GaLV Env, and BST-2/Tetherin
    Song, Yul Eum
    Cyburt, Daniel
    Lucas, Tiffany M.
    Gregory, Devon A.
    Lyddon, Terri D.
    Johnson, Marc C.
    VIRUSES-BASEL, 2018, 10 (10):
  • [3] β-TrCP Dependency of HIV-1 Vpu-Induced Downregulation of CD4 and BST-2/Tetherin
    Blanchet, Fabien P.
    Mitchell, J. P.
    Piguet, Vincent
    CURRENT HIV RESEARCH, 2012, 10 (04) : 307 - 314
  • [4] Sites of Action of HIV-1 Vpu in BST-2/Tetherin Downregulation
    Arias, Juan F.
    Iwabu, Yukie
    Tokunaga, Kenzo
    CURRENT HIV RESEARCH, 2012, 10 (04) : 283 - 291
  • [5] BST-2 is rapidly down-regulated from the cell surface by the HIV-1 protein Vpu: Evidence for a post-ER mechanism of Vpu-action
    Skasko, Mark
    Tokarev, Andrey
    Chen, Cheng-Chang
    Fischer, Wolfgang B.
    Pillai, Satish K.
    Guatelli, John
    VIROLOGY, 2011, 411 (01) : 65 - 77
  • [6] Identification of residues in the BST-2 TM domain important for antagonism by HIV-1 Vpu using a gain-of-function approach
    Yoshida, Takeshi
    Kao, Sandra
    Strebel, Klaus
    FRONTIERS IN MICROBIOLOGY, 2011, 2
  • [7] HIV-1 Vpu and BST-2/Tetherin: Enemies at the Gates
    Tokunaga, Kenzo
    CURRENT HIV RESEARCH, 2012, 10 (04) : 275 - 276
  • [8] Ubiquitination of BST-2 Protein by HIV-1 Vpu Protein Does Not Require Lysine, Serine, or Threonine Residues within the BST-2 Cytoplasmic Domain
    Gustin, Jean K.
    Douglas, Janet L.
    Bai, Ying
    Moses, Ashlee V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (18) : 14837 - 14850
  • [9] HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment
    Hauser, Heiko
    Lopez, Lisa A.
    Yang, Su Jung
    Oldenburg, Jill E.
    Exline, Colin M.
    Guatelli, John C.
    Cannon, Paula M.
    RETROVIROLOGY, 2010, 7
  • [10] HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes
    Iwabu, Yukie
    Fujita, Hideaki
    Kinomoto, Masanobu
    Kaneko, Keiko
    Ishizaka, Yukihito
    Tanaka, Yoshitaka
    Sata, Tetsutaro
    Tokunaga, Kenzo
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (50) : 35060 - 35072